Chen-Ming Yu
Directeur Général chez TCG Crossover Management LLC
Fortune : 45 M $ au 30/04/2024
Profil
Chen-Ming Yu has founded TCG Crossover Management LLC in 2021.
He is currently working as a Director at Rempex Pharmaceuticals, Inc., Synaptic Medical International, Artios Pharma Ltd., Arbor Biotechnologies, Inc., ADARx Pharmaceuticals, Inc., Shanghai ShouTi Biotechnology Co. Ltd., and Upstream Bio, Inc. Dr. Yu has previously worked as the Chairman at Surgical Specialties Corp.
from 2017 to 2020.
He has also held positions as a Director at Pavad Medical, Inc., SentreHEART, Inc., Naryx Pharma, Inc., Sagent Holdings Co., KALA BIO, Inc., Sagent Pharmaceuticals, Inc., Nora Therapeutics, Inc., Tarsus China Ltd., PrinJohnson BioPharm, Inc., Outpost Medicine, Inc., German Medical Technology Co., Ltd., Jian Rui Bao, Structure Therapeutics, Inc., Eli Lilly & Co., aQuantive, Inc., Vivo Capital LLC, Bain & Co., Inc., Nabriva Therapeutics GmbH, Sagent Pharmaceuticals, Inc., Nanjing King-friend Biochemical Pharmaceutical Co., Ltd., and China Kanghui Holdings.
Dr. Yu's education includes an undergraduate degree from Harvard University, an MBA from Stanford Graduate School of Business, and a doctorate from Stanford School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/02/2023 | 3 458 242 ( 2,47% ) | 45 M $ | 30/04/2024 |
Postes actifs de Chen-Ming Yu
| Sociétés | Poste | Début |
|---|---|---|
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
| Synaptic Medical International | Directeur/Membre du Conseil | - |
TCG Crossover Management LLC
 TCG Crossover Management LLC Investment ManagersFinance TCG Crossover Management LLC (TCG Crossover Management) is a venture capital firm founded in 2021 by Chen-Ming Yu. The firm is headquartered in Palo Alto, California. | Directeur Général | 01/01/2021 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Directeur/Membre du Conseil | 01/10/2021 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Directeur/Membre du Conseil | - |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Chen-Ming Yu
| Sociétés | Poste | Fin |
|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 24/03/2021 |
| ░░░░ ░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Chen-Ming Yu
| Harvard University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| Stanford School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| KALA BIO, INC. | Health Technology |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Entreprise privées | 26 |
|---|---|
aQuantive, Inc.
 aQuantive, Inc. Advertising/Marketing ServicesCommercial Services aQuantive, Inc. designs and develops digital marketing services and provides related online solutions. The company offers services such as online media buying and planning, ad campaign management, e-mail direct marketing, search engine optimization, and data warehousing and analysis. The company was founded in 1997 and is headquartered in Seattle, WA | Commercial Services |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
Pavad Medical, Inc.
 Pavad Medical, Inc. Medical/Nursing ServicesHealth Services Pavad Medical, Inc. provides healthcare services and equipment. The firm also develops medicine for the treatment of sleep apnea and snoring diseases. The company was founded in 2002 and is headquartered in Fremont, CA. | Health Services |
SentreHEART, Inc.
 SentreHEART, Inc. Medical SpecialtiesHealth Technology SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA. | Health Technology |
Naryx Pharma, Inc.
 Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | Health Technology |
Sagent Holdings Co.
 Sagent Holdings Co. Pharmaceuticals: MajorHealth Technology Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Surgical Specialties Corp.
 Surgical Specialties Corp. Medical SpecialtiesHealth Technology Surgical Specialties Corp. manufactures medical products. It specializes in designing and manufacturing of surgical knives and wound closure products. The firm offers suture needles, sutures, microsurgical cutting instruments, eye garters, and ophthalmic cannulas. The company is headquartered in Westwood, MA. | Health Technology |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
China Kanghui Holdings
 China Kanghui Holdings Medical SpecialtiesHealth Technology China Kanghui Holdings operates as a holding company that develops, manufactures and markets orthopedic implants. The company was founded by Yi Kang Jiang on April 19, 2006 and is headquartered in Changzhou, China. | Health Technology |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Health Technology |
| Tarsus China Ltd. | |
| Stanford Medical Alumni Association | |
| Synaptic Medical International | |
PrinJohnson BioPharm, Inc.
 PrinJohnson BioPharm, Inc. Pharmaceuticals: MajorHealth Technology PrinJohnson BioPharm, Inc. focuses on the development and sale of generic pharmaceuticals. The company is headquartered in Cranbury, NJ. | Health Technology |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Commercial Services |
German Medical Technology Co., Ltd.
 German Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology German Medical Technology Co., Ltd. develops, manufactures, and sells disposable and implantable medical devices. | Health Technology |
TCG Crossover Management LLC
TCG Crossover Management LLC Investment ManagersFinance TCG Crossover Management LLC (TCG Crossover Management) is a venture capital firm founded in 2021 by Chen-Ming Yu. The firm is headquartered in Palo Alto, California. | Finance |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Commercial Services |
| Jian Rui Bao |
